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A~tract 
Using the patch-clamp method, we found that methylene blue (MB), a free radical inhibitor of guanylyl cyclase, 
activated large. Ca-'+-aetivated K ~ channels (BKc,,J in either cell anached or excised, inside-out patches of hmnan 
mesangial cells in culture. Since BKc~ are important feedback regulators o1 contraction of smooth muscle and mesangial 
cells, these results indicate that MB may be an important opener of BKc,, channels and a regulat0r of vascular volume and 
resi,xtanee. 
Ke~vords: Methylene b ue Potass um on ch nne Ca 2. ~lcdv~Ted BKc,~) Guanvlyl cyclase nh b or LYS3583 Patch clamp 
It has been documented in several studies that 
vasorelaxams, uch as nitric oxide (NO) and atrial 
natriuretic peptide, attenuate contraction of smooth 
muscle [1-3] and mesangial cells [4,5], in part, by 
activating BKca via a cGMP-.dependent signal trans- 
duction pathway. In our laboratory, it was shown that 
the guanylyl cyclase inhibitor, LY83583, inhibited 
the activation of BKc., by nitropmsside, an NO donor 
[4]. However, methylene blue, a free radical inhibitor 
of guanylyl eyelase, failed to inhibit the activation of 
BKc~ by nitropmsside [4]. We therefore determined 
if  methylene blue directly activates BKc~ in human 
mesangial cells. These results could partially explain 
the controversial finding of direct activation of BKco 
by nitric oxide and the conflicting reports regarding 
the multiple effects of methylene blue on smooth 
muscle and mesangial t, ell tone [6-9]. Moreover, 
" Cnrresponding author (at address a). Fax: +- I (713) 7941197. 
because BK ca are important regulators of contraction 
of vascular smooth muscle and glomerular mesangial 
cells, an opener of these channels would be expected 
to influence blood pressure and volume and could 
thereby have clinical and therapeutic significance. 
Mesangial cells were isolated from human kidneys 
and clqtured using the following standard techniques 
[10]. Mesangial cells were plated in Waymouth's 
culture media (pH ~ 7.4), supplemented with 15 mM 
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid 
(Hepes), 2.0 mM glutamine, 0.66 U /ml  insulin, 1.0 
mM sodium pyp~vate, 0.1 mM nonessential amino 
acids, antibiotic solution (100 units/ml penicillin and 
100 #g/ml  streptomycin) and 17% (v /v)  newborn 
calf serum. Subpassages four through ten were used 
in all experiments. It was shown by Mene et al. [11] 
that this generation span of MC maintain a constant 
phenotype and typical smooth muscle-like spindle 
shape. Moreover. our laboratory has shown that these 
generations maintain the consistent transcription [12] 
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and expression of BKc, , responsive to cGMP- 
activated protein kinase [5.13]. 
Mcsangial cells were prepared for single channel 
analysis using standard patch-clamp techniques previ- 
ously described [13,14]. Pipette and bath solutions 
contained (in raM): 10 Hepes (pH = 7.4). 2 MgCI~ 
and either I'40 KCI or 135 NaCI plus 5 KCI. The free 
Ca '+ concentration of the bath (initially 1.0 raM) 
was adjusted to lower concentrations by buffering 
with EGTA as described previously [15]. 
After obtaining gigaohm seals, current recordings 
were made with the electrode on the cell surface (ceil 
attached) or after withdrawing the patched membrane 
(excb,ed, inside-out). The unitary current (i: defined 
as zero for C) was determined as the mean of the best 
fit Gaussian distribution of the amplitude histograms. 
Channels were considered in an open state (St when 
the current was >(n -  1 /2) i  and <(nO 1/2) i .  
where it is the number of current levels. The open 
state probability of a channel (P,,) is defined as the 
time spent in S divided hy :he total time of the 
recording. In nil cases. -Vp  is the hnldigJg potential 
relative to the pipette. 
All chemicals were purchased from Sigmu (St. 
Louis). except LY83583, which was purchased fl'om 
Calbiochem (La Jolla. CA). For paired data and 
multiple comparisons, the paired t-test and an analy- 
sis of variance plus the Student-Newman-Keuls  lest, 
respectively, were used to establish statistical differ- 
ences ( p _< 0+05), 
Table ] 
The effecl of methyiene blue (MB) and L¥83583 on the activa- 
liun of BKc, ~ by nilropmsside 
Agents ~, 
Control 1131 0 a3+o.01 
Nitroprusside (6) 0.38 + 0.07 " 
Nilroprusside + LY83583 (41 O,03 + O.nl 
Nilropmssida + MB {61 0.46 _+ n.n7 " 
Values are open probability of UKc, , in cell ,~ttached patches 
bathed with 135 mM NaCI plus 5 mM KCI and I mM CaCI z. 
Vp-8n inV. Nitroprusside O.l raM. methylene blue= 0.1 
raM. LY83583-1.0 mM ' p_<O.O5 w. control (ANOVA+ 
SNK test). 
Fig. I shows current tracings of BKc, ~ in cell 
attached patches. As shown in Fig. I,,~+ nitroprusside 
(0.1 raM) activated BKc.  from a Po of <0.05  to a 
peak of 0.57. Over the next two minutes BKc+ 
activity returned to baseline, As shown in Fig. 1B. 
addition of nitroprusside in the presence of methylene 
blue (0.1 raM) activated BKc+ to a sustained P,, of 
0.47. As shown in Fig. IC, BKc,  were not activated 
by nilroprusside in the presence of LY83583 (1+0 
/aM). 
A summary of the effects of methylene blue and 
LY83583 on the activation of BKc ,  by nitroprusside 
is shown m Table I. In cell attached patches, nitro-. 
prusside activated BKca significantly in the absence 
or presence of methylene blue. However, nitroprus- 
side failed to acti',ate BKca in the presence of 
LY83583. 
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Fig, 2. (AI Tracings of BKc, in a reprcsentalk'c excised, inside- 
out patch ( -  V e ~ -40 mV and [Ca -~" ], = 1.0 aM) showing the 
effects of methylene blue. In the upper Iracing. P,, increased 
from 0.08 to 0.22 ulxm addiliun uf IO/~M methylene blue. In Ihe 
lower tracing, 0.1 mM methylene blue activated nKc~ to n.54. 
(B) Current racings howing that LY83583 did not affect BKt..~ 
under the same conditions. Open probability was <0.05 betbre 
and after the addition of LY83583 (lop tracing = 1,0 .tiM, ~.utnm 
tracing = 0.1 raM). 
The representative current tracings (excised, in- 
side-out) of Fig. 2A show that methylene blue acti- 
vated BKc, ~ directly in a dose-dependem anner, 
Upon addition of I0 p,M and 0.1 mM methylene 
blue, P, increased from 0.08 to 0.22 and 0.54, 
respectively. In six paired, excised, inside-out experi- 
ments (--Vp = --4~1 mV, [Ca2+]i 1.0 /.tM) methy- 
lene blue significantly (p  < 0.001) activated BKc, ~ 
from a P~, of 0.09 4- 0.02 to 0.45 4- 0.05. In contrast. 
as shown by the representati'~'e current tracings of 
125 
Fig. 213. 1-Y83583 (0.1 mM and 1.0 txM) did not 
affect BKc , .  In four paired experiments, LY83583 
did not activate P, Kc, ' (p  = 0.6A.). Thu~. methylene 
blue. but not LY83583. activated BKc~ directly from 
the intracellular side. 
It was timud that 0.1 mM nlethylene blue did itot 
afl?ct significantly (p  = 0.18) solution pH (7.37 +_ 
0.01 and 7.38 _+ 0.01. respectively, before anti t i ler 
addition of methylene blue). Thus. the effects of 
methylene blue on BKc~ cannot be anributed to 
changing xolution pH. 
As an inhibitor of guanylyl cyclase [16.17]. methy- 
lene blue has been used in several studies to deter- 
mine the role for cGMP in relaxation of smomh 
muscle cells [18-20]. BKc, , channels hyperpolarize 
the membrane and inhibit contraction of mesangiat 
cells [4] and vascular smooth muscle [22] by reducing 
vo!tage-gated Ca entry. Although some studies show 
that meth3,1ene blue inhibits arterial relaxation by 
cGMP-stimtduling relaxants [18-21]. other studies 
show methylene blue either had no effect [7-9] or 
augmcntcd NO-induced relaxation of vascular smooth 
muscle [6]. It is possible that these conflicting studies 
are due to simultaneous inhibition of gnaayiate cy- 
clase and activation of BKc, , channels. 
The finding that methylene blue directly activates 
BK,:;~ can partially explain the effects reported 1",3' 
Bolotina. who found that NO activated BKca nfter 
addition of methylene blue [23]. Although Bolotina 
also found a direct activation by NO of BKc,  in 
excised pinches, it is likely that many intracenular 
compounds and enzymes, such as guanylyl cyctase 
and protein kinase G are present in the excised patch. 
A recent study in thi~ laboratory provided evidence 
that cGMP-actlvoted kinase was present with BKc< ` 
in excised patches [4]. The absence of direct BKc, 
activation by NO was also supported by the recent 
study by McCobb et al. who tbund no direct effect of 
nitroprusside on the gene product for hs lo ,  a human 
BKc, , of vascular smooth muscle expressed in XeJ io -  
pus  oocytes [24]. 
It is postulated that methylene blue inhibits soluble 
guanylyl cycl',se by oxidation of its heine center [20]. 
However. because methylene blue is an electron ac- 
ceptor, multiple actions, other than specifically in- 
hibiting guanylyl eyeluse, would be expected. Methy- 
lene blue (.'~ttlses the release of noritdrenallne from 
adrenergic nerve endings [25]. inhibits production of 
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prostacyclin in arteries [26], and inhibits release of 
NO fi'om organic nitrates [27]. 
In conclusion, our results can explain some of the 
paradoxical and ambiguous effects of methylene blue 
on the response of vascular cells to relaxing agents. 
Based on these results, LY83583 would be a more 
suitable agent for determining the signaling pathways 
for relaxing agents. The notion that methylene blue 
can open BKc,  ` channels could have therapeutic on- 
sequences for regulating glomerular filtration rate or 
vascular smooth muscle tension, 
The human glomerular mesangial  cells were a 
generous gift fi'um Hanna Abboud (U of TX-HSC.  
San Antonio). Steve Sansom was supported by Amer- 
ican Diabetes Association award #89,  
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